Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Gastric cancer is a major cause of cancer mortality and exhibits significant heterogeneity.
• Existing classifications do not fully capture the molecular diversity of gastric cancer.
• There is a need for clinically relevant molecular subtypes to guide treatment and research.

Purpose of the Study:

• To establish clinically relevant molecular subtypes of gastric cancer.
• To link these subtypes to distinct molecular alterations, disease progression, and prognosis.
• To provide a unified framework for translational research in gastric cancer.

Main Methods:

• Analysis of gene expression data to identify molecular subtypes.
• Targeted sequencing and genome-wide copy number microarrays to characterize molecular alterations.
• Validation of subtypes in independent patient cohorts.

Main Results:

• Four molecular subtypes were identified: mesenchymal-like, microsatellite-unstable, TP53-active, and TP53-inactive.
• The mesenchymal-like subtype showed the worst prognosis and highest recurrence (63%).
• The microsatellite-unstable subtype had the best prognosis and lowest recurrence (22%).
• TP53-active and TP53-inactive subtypes presented intermediate prognoses, with TP53-active faring better.

Conclusions:

• The identified molecular subtypes represent a significant advancement in understanding gastric cancer heterogeneity.
• These subtypes correlate with distinct clinical outcomes and molecular features.
• The proposed classification provides a robust framework for future clinical and preclinical studies in gastric cancer.